by admin | Mar 31, 2025 | HCP
Support & Contact We’d love to hear from you. Please reach out to call 1-877-375-0825 for General Information/Opt In Medical Affairs Inquiry/Adverse Event Reporting. Alternatively, you can use the form below to select your reason for contacting us. Select...
by admin | Mar 31, 2025 | HCP
Call 1-877-649-3867 to Enroll Today! Patient Assistance For Meeting Your Patient’s Needs Nobelpharma Connect strives to deliver personalized services and support for patients and their Healthcare Providers. Personalized Services and Support At Nobelpharma...
by admin | Mar 31, 2025 | HCP
Resources & Support HYFTOR® Approved Specialty Pharmacies HYFTOR® is only available through our approved Limited Distribution Network of Specialty Pharmacies. Please click on the states below to find an approved location near you. These specialty pharmacies are...
by admin | Mar 31, 2025 | HCP
Facial Angiofibroma: One of the Most Common and Visible Signs of TSC Tuberous Sclerosis Complex Tuberous sclerosis complex (TSC) is a genetic multisystemic disease that affects approximately 1 in 6,000 live births.1 It causes noncancerous tumors, or hamartomas, to...
by admin | Mar 31, 2025 | HCP
About HYFTOR® (sirolimus topical gel) 0.2% HYFTOR® is the first and only topical medication approved by the FDA to treat facial angiofibroma associated with tuberous sclerosis complex (TSC) in adults and children 6 years and older. HYFTOR® is a clear gel that contains...
by admin | Mar 31, 2025 | HCP
The first and only FDA-approved topical gel for facial angiofibroma associated with tuberous sclerosis in adults and children 6 years and older HYFTOR® (sirolimus topical gel) 0.2% isan mTOR inhibitor in a clear gel. Not actual patients. Individual results may vary....
Recent Comments